Navigation Links
New Brain Tumor Vaccine Developed By US Scientists

Researchers from the U.S have now developed a new vaccine, believed to fight against glioblastoma multiforme or GBM, a form of brain tumor//. The vaccine is hoped to fight brain tumor by delaying its progression.

Scientists say the vaccine increased survival rates by at least 18 months for the 23 patients of glioblastoma multiforme that it was tested on, reported the online edition of BBC News.

One in four brain tumours are glioblastoma multiforme (GBM), the most aggressive form of the primary brain tumours known collectively as gliomas.

These tumours arise from the supporting glial cells of the brain. These growths do not spread throughout the body like other forms of cancer, but cause symptoms by invading the brain.

The developed vaccine, an easy-to-use 'off-the-shelf' treatment, could potentially help half of all patients with glioblastoma multiforme (GBM), said Amy Heimberger, assistant professor of neurosurgery at the MD Anderson Cancer Center, Texas.

Trial results showed that the vaccine significantly delays the progression of tumours until the cancer finds a new way to grow. A larger trial of the vaccine, which works by targeting a protein thought to drive the tumour's spread, is now planned.

Edited IANS
'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. “Brain fingerprinting”- The new lie detectr
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Virus Combats Brain Tumour
6. Nasal Spray Could Take Drugs Directly to Brain
7. Control of anger disorder connected to Brain Dysfunction
8. High Levels of Protein Linked to Brain Shrinkage
9. Brain damage affects artistic skill
10. Brain cells protected by new compounds
11. Brain changes observed in people with sleep apnoea
Post Your Comments:
(Date:7/9/2008)... Radiotherapy Clinics of Georgia (RCOG) has beg...ing campaign. RCOG is renowned for their ProstRcis...st documented prostate cancer cure rates in the wo...B) July 9, 2008 -- Radiotherapy Clinics of Georgia...r click campaign that incorporates geo targeting f...
(Date:7/9/2008)... This first-of-its-kind Diamond Elite Walk In ...aze, chip or develop cracks. , ...wo years in development, The Kitchen Bath Store ( ...e newest design in walk-in tubs: Diamond Elite Wa...nch-high entry and is 3-times thicker and stronger...
(Date:7/9/2008)... While SmartLipo has swept the nation with its ... removal procedure has leaped forward. Colorado pl...to be the first in his state to offer the next gen...o one of only two plastic surgeons authorized to t...e. , Lone Tree, CO (PRWEB...
(Date:7/9/2008)...w figures on assisted reproduction technology (ART...in the use of ICSI (intracytoplasmic sperm injecti...of the European Society of Human Reproduction and ...sday). Researchers believe that some countries may... the most recent year for which data have been co...
Breaking Medicine News(10 mins):Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 2Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 3Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 3Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 3Health News:Researcher say that ICSI may be over-used in some countries 2Health News:Researcher say that ICSI may be over-used in some countries 3
...ise that constant stress can make people sick, and...study focused on 119 men and women who were taking...caregivers was compared with that of 106 people of...e stress of constant care giving. Blood tests show...
...investigators more than 10 million children worldw...nd many of them preventable with existing medical ...these nations has dropped over the past half centu...f of the deaths in children under 5 take place in ...
...le who are bitten by animals poses little problem ... another human? That’s the question researchers se...onth’s Otolaryngology -- Head and Neck Surgery. Th...ords in Galveston, Texas, identified several key a...
... that early detection is important for preventing ...be as easy as mirrors with no tricks, just light.J...e’s lucky doctors were able to treat him despite a...ound a primary, which is what you call the skin ca...
Other Medicine News:
(Date:7/8/2008)...RNewswire/ -- Avir Green Hills Biotechnology,start...cine deltaFLU,against pandemic influenza. This nov...n the deletion of the NS1 gene has shown superior,...e biotech company sets,yet another milestone in th...m of Phase I Study, The randomized, double-blind ...
(Date:7/8/2008).../- After meeting on July 1st and,2nd ...betes drugs should,undergo trials to rule out card...f US endocrinologists agree with this recommendati...diovascular and metabolic primary market,research ...obal Life,Sciences Industry., On July 3rd AlphaDe...
(Date:7/8/2008)...eets primary endpoints in ENGAGE Trial, KENILWORT...-Plough,Corp., (NYSE: SGP ) announced today that ...follicle stimulant (SFS) met its primary endpoints...presented during a,Schering-Plough-sponsored sympo...ciety of Human Reproduction and Embryology (ESHRE)...
(Date:7/7/2008)...proves Cognition and is Well Tolerated in ...ndings Warrant Further Development in Huntington,s...Today at 5:00 p.m. EDT -, SAN FRANCISCO, July 7 /... MDVN ) today announced top-line results of a Pha...imebon(TM) significantly improved cognitive,functi...
Breaking Medicine Technology:Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 2Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 3AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 1UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 2Prime Therapeutics Receives TIPPS Certification 729 1Prime Therapeutics Receives TIPPS Certification 729 2Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences 727 1Standard Management Announces OTCBB Listing 725 1Standard Management Announces OTCBB Listing 725 2
...monstrate Significant Survival Benefit in,Liver Ca...ll/ -- Bayer,HealthCare Pharmaceuticals Inc. and O...avar(R) (sorafenib) tablets significantly,extended...carcinoma,(HCC), or primary liver cancer versus th...). Results were presented at the 43rd,annual meeti...
...NESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nasdaq: GN...y and,efficacy data from the clinical development ...nted in a poster session on,gastrointestinal cance...linical Oncology in Chicago, IL by Dr. Mitchell Po...sion of the posters then,concluded the Saturday mo...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4
...igation system for ENT, cranial and spine procedur...y, critical zones visible during tracking. Image f...n freezes image, snapshot can be taken of frozen i...the microscope, low profile receiver attachment. A...
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Bacon Cranial Rongeur
Cushing Pituitary Rongeur
Medicine Products: